P. Nickel

Publications86
h-index27
Citations1,997
Highly Influential Citations109
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • G. Burnstock
  • 1,754 Publications • 99,522 Citations
  • G. Lambrecht
  • 212 Publications • 5,414 Citations
  • M. Freissmuth
  • 369 Publications • 11,156 Citations
  • M. Kassack
  • 168 Publications • 5,248 Citations
  • Publications
  • Influence
Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors
View on Elsevier
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist
View on Elsevier
Suramin analogues as subtype-selective G protein inhibitors.
TLDR
The results show that it is possible to design G protein inhibitors that target the effector binding site on the alpha subunits, and selected suramin is selective for recombinant Gsalpha-s and recombinant Go alpha.
View on PubMed
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors
TLDR
The subnanomolar potency at rP2X1 receptors and the rank order of potency, P 2X1 >> P2X3 > P 2Y1 > P2Y2 > ecto-nucleotidases, make NF449 unique among the P2 receptor antagonists reported to date.
View on Springer
NF449, a novel picomolar potency antagonist at human P2X1 receptors.
View on PubMed
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor
View on Elsevier
Gsalpha-selective G protein antagonists.
TLDR
Two compounds, NF503 and NF449, fulfill essential criteria for Gsalpha-selective antagonists and demonstrate the feasibility of subtype- selective G protein inhibition.
View on PubMed
Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
TLDR
This work moves closer to the ideal goal of classifying the recombinant and native P2 receptor subtypes on the basis of antagonist profiles, and focuses on structure-activity relationships of PPADS and suramin analogues.
View on PubMed
Suramin and suramin analogs activate skeletal muscle ryanodine receptor via a calmodulin binding site.
TLDR
It is concluded that NF307 and suramin interact directly with a calmodulin binding domain of the ryanodine receptor, a potent calcium-sensitizing effect that may represent a lead compound in the search of synthetic ryanode receptor ligands.
View on PubMed
Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors.
View on PubMed
...
...